BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37625115)

  • 21. Sirtuin 2 expression suppresses oxidative stress and senescence of nucleus pulposus cells through inhibition of the p53/p21 pathway.
    Yang M; Peng Y; Liu W; Zhou M; Meng Q; Yuan C
    Biochem Biophys Res Commun; 2019 Jun; 513(3):616-622. PubMed ID: 30981502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATRX-Deficient High-Grade Glioma Cells Exhibit Increased Sensitivity to RTK and PDGFR Inhibitors.
    Pladevall-Morera D; Castejón-Griñán M; Aguilera P; Gaardahl K; Ingham A; Brosnan-Cashman JA; Meeker AK; Lopez-Contreras AJ
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignancies.
    Oppel F; Tao T; Shi H; Ross KN; Zimmerman MW; He S; Tong G; Aster JC; Look AT
    PLoS Genet; 2019 Apr; 15(4):e1008039. PubMed ID: 30970016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis.
    Xie Y; Tan Y; Yang C; Zhang X; Xu C; Qiao X; Xu J; Tian S; Fang C; Kang C
    Cancer Biol Med; 2019 Nov; 16(4):784-796. PubMed ID: 31908895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATRX immunostaining predicts IDH and H3F3A status in gliomas.
    Ebrahimi A; Skardelly M; Bonzheim I; Ott I; Mühleisen H; Eckert F; Tabatabai G; Schittenhelm J
    Acta Neuropathol Commun; 2016 Jun; 4(1):60. PubMed ID: 27311324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical expression of ATRX in gliomas.
    Jalal JA; Rowandizy AIS; Ismael AT
    Cell Mol Biol (Noisy-le-grand); 2020 Aug; 66(7):131-135. PubMed ID: 33287933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinal interneuron survival requires non-cell-autonomous Atrx activity.
    Lagali PS; Medina CF; Zhao BY; Yan K; Baker AN; Coupland SG; Tsilfidis C; Wallace VA; Picketts DJ
    Hum Mol Genet; 2016 Nov; 25(21):4787-4803. PubMed ID: 28173139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATRX is a regulator of therapy induced senescence in human cells.
    Kovatcheva M; Liao W; Klein ME; Robine N; Geiger H; Crago AM; Dickson MA; Tap WD; Singer S; Koff A
    Nat Commun; 2017 Aug; 8(1):386. PubMed ID: 28855512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection Reveals a Modification of SIRT2 Critical for Chromatin Association.
    Pereira JM; Chevalier C; Chaze T; Gianetto Q; Impens F; Matondo M; Cossart P; Hamon MA
    Cell Rep; 2018 Apr; 23(4):1124-1137. PubMed ID: 29694890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic Inactivation of ATRX Leads to a Decrease in the Amount of Telomeric Cohesin and Level of Telomere Transcription in Human Glioma Cells.
    Eid R; Demattei MV; Episkopou H; Augé-Gouillou C; Decottignies A; Grandin N; Charbonneau M
    Mol Cell Biol; 2015 Aug; 35(16):2818-30. PubMed ID: 26055325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2.
    Modrek AS; Golub D; Khan T; Bready D; Prado J; Bowman C; Deng J; Zhang G; Rocha PP; Raviram R; Lazaris C; Stafford JM; LeRoy G; Kader M; Dhaliwal J; Bayin NS; Frenster JD; Serrano J; Chiriboga L; Baitalmal R; Nanjangud G; Chi AS; Golfinos JG; Wang J; Karajannis MA; Bonneau RA; Reinberg D; Tsirigos A; Zagzag D; Snuderl M; Skok JA; Neubert TA; Placantonakis DG
    Cell Rep; 2017 Oct; 21(5):1267-1280. PubMed ID: 29091765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Alternatively Spliced Sirtuin 2 Isoform 5 Inhibits Hepatitis B Virus Replication from cccDNA by Repressing Epigenetic Modifications Made by Histone Lysine Methyltransferases.
    Piracha ZZ; Saeed U; Kim J; Kwon H; Chwae YJ; Lee HW; Lim JH; Park S; Shin HJ; Kim K
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32493816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of sirtuin 2 protein nuclear localization in glioma: an immunohistochemical study.
    Imaoka N; Hiratsuka M; Osaki M; Kamitani H; Kambe A; Fukuoka J; Kurimoto M; Nagai S; Okada F; Watanabe T; Ohama E; Kato S; Oshimura M
    Oncol Rep; 2012 Sep; 28(3):923-30. PubMed ID: 22735931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation.
    Serrano L; Martínez-Redondo P; Marazuela-Duque A; Vazquez BN; Dooley SJ; Voigt P; Beck DB; Kane-Goldsmith N; Tong Q; Rabanal RM; Fondevila D; Muñoz P; Krüger M; Tischfield JA; Vaquero A
    Genes Dev; 2013 Mar; 27(6):639-53. PubMed ID: 23468428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic repression of Wnt receptors in AD: a role for Sirtuin2-induced H4K16ac deacetylation of Frizzled1 and Frizzled7 promoters.
    Palomer E; Martín-Flores N; Jolly S; Pascual-Vargas P; Benvegnù S; Podpolny M; Teo S; Vaher K; Saito T; Saido TC; Whiting P; Salinas PC
    Mol Psychiatry; 2022 Jul; 27(7):3024-3033. PubMed ID: 35296808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The chromatin remodeling protein ATRX positively regulates IRF3-dependent type I interferon production and interferon-induced gene expression.
    Stilp AC; Scherer M; König P; Fürstberger A; Kestler HA; Stamminger T
    PLoS Pathog; 2022 Aug; 18(8):e1010748. PubMed ID: 35939517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma.
    Koschmann C; Calinescu AA; Nunez FJ; Mackay A; Fazal-Salom J; Thomas D; Mendez F; Kamran N; Dzaman M; Mulpuri L; Krasinkiewicz J; Doherty R; Lemons R; Brosnan-Cashman JA; Li Y; Roh S; Zhao L; Appelman H; Ferguson D; Gorbunova V; Meeker A; Jones C; Lowenstein PR; Castro MG
    Sci Transl Med; 2016 Mar; 8(328):328ra28. PubMed ID: 26936505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoallelic IDH1 R132H Mutation Mediates Glioma Cell Response to Anticancer Therapies via Induction of Senescence.
    Zhan D; Ma D; Wei S; Lal B; Fu Y; Eberhart C; Laterra J; Ying M; Li Y; Meeker A; Lopez-Bertoni H; Xia S
    Mol Cancer Res; 2021 Nov; 19(11):1878-1888. PubMed ID: 34348994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of hepatic ATRX in
    Rowland ME; Jiang Y; Beier F; Bérubé NG
    Aging (Albany NY); 2018 Jun; 10(6):1223-1238. PubMed ID: 29883366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ATRX guards against aberrant differentiation in mesenchymal progenitor cells.
    Fang Y; Barrows D; Dabas Y; Carroll TS; Singer S; Tap WD; Nacev BA
    Nucleic Acids Res; 2024 May; 52(9):4950-4968. PubMed ID: 38477352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.